Powered by

Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference

Jan 02, 2019 - GlobeNewswire
Event Announcements

ALPHARETTA, Ga., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that its Chief Executive Officer and President, Daniel White, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 8:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.

A live webcast of th...